Company
URGN · CIK 0001668243
Sale of 1,519 shares at $42.54 per share.
Reporting Person Smith Jason Drew · Officer Title General Counsel · Transaction Code S
Traded Sep 8, 2026 · Disclosed Sep 9, 2026
Source: SEC Form 4 · 0001437749-26-029963 · filed 2026-09-09 · View filing →
Sale of 871 shares at $42.92 per share.
Reporting Person Schoenberg Mark · Officer Title Chief Medical Officer · Transaction Code S
Traded Sep 8, 2026 · Disclosed Sep 9, 2026
Source: SEC Form 4 · 0001437749-26-029965 · filed 2026-09-09 · View filing →
Acquisition (code M) of 3,334 shares; price not stated (see filing).
Reporting Person Smith Jason Drew · Officer Title General Counsel · Transaction Code M
Traded Sep 7, 2026 · Disclosed Sep 9, 2026
Source: SEC Form 4 · 0001437749-26-029963 · filed 2026-09-09 · View filing →
Acquisition (code M) of 1,667 shares; price not stated (see filing).
Reporting Person Schoenberg Mark · Officer Title Chief Medical Officer · Transaction Code M
Traded Sep 7, 2026 · Disclosed Sep 9, 2026
Source: SEC Form 4 · 0001437749-26-029965 · filed 2026-09-09 · View filing →
Acquisition (code M) of 2,000 shares; price not stated (see filing).
Reporting Person Robinson James A. Jr. · Transaction Code M
Traded Aug 26, 2026 · Disclosed Aug 28, 2026
Source: SEC Form 4 · 0001437749-26-029175 · filed 2026-08-28 · View filing →
Sale of 60,677 shares at $47.05 per share.
Reporting Person Schoenberg Mark · Officer Title Chief Medical Officer · Transaction Code S
Traded Aug 20, 2026 · Disclosed Aug 24, 2026
Source: SEC Form 4 · 0001437749-26-028840 · filed 2026-08-24 · View filing →